Disclaimer: This page is for Health Care Professionals only.
This live webinar, taking place between 17:00–18:00 CET on Wednesday 10 November, will see a multidisciplinary panel – Prof. Raja Atreya, Prof. Ernest Choy and Dr Elena Ricart – answer the question ‘Are all JAK inhibitors the same?’ from an immunology, rheumatology and gastroenterology perspective. Through a series of engaging presentations, the expert faculty will explore the rationale for, and pharmacological profiles of JAK inhibitors in inflammatory diseases, and the potential clinical implications of preferential JAK1 inhibition. This webinar includes a live Q&A.
Professor Raja Atreya
University Hospital Erlangen, Erlangen, Germany
Professor Raja Atreya is Senior Physician and Head of the IBD Unit, Outpatient Clinic and Clinical Study Centre at University Hospital Erlangen. His work focusses on identifying response predictors (e.g. molecular endoscopy) and resistance mechanisms to biological therapies in IBD. His career has been well decorated — he received the Theodor-Frerichs Award of the German Society for Internal Medicine, Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers from the Paul Ehrlich Foundation, UEG’s Rising Star Award and the International Award of the American College of Gastroenterology.
Professor Ernest Choy
Cardiff University, Cardiff, UK
Professor Ernest Choy is Head of Rheumatology and Translational Research at the Division of Infection and Immunity, and Director of the Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre at Cardiff University School of Medicine. He is also Honorary Consultant Rheumatologist at the University Hospital of Wales and Clinical Lead of the Welsh Arthritis Research Network. His main research interest is the efficacy of new treatment strategies in rheumatic diseases. He has published widely in major journals and lectures on treatments for rheumatic diseases.
Dr Elena Ricart
Hospital Clínic de Barcelona, Barcelona, Spain
Dr Elena Ricart is a consultant at the Gastroenterology Department of Hospital Clínic de Barcelona and Associate Professor at the University of Barcelona. Her main interests include IBD and biological/cell therapy. She has authored 120 peer-reviewed articles on IBD. She is a member of the Spanish Medical Association for the Study of CD and UC, ECCO, the Spanish Association of Gastroenterology (AEG), Catalan Society of Digestology (SCD), the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBER-EHD).